Nucleobindin activators encompass a diverse array of chemical compounds that, through different mechanisms, enhance the functional activity of nucleobindin, particularly within calcium signaling pathways. Forskolin and IBMX act by increasing the levels of cyclic nucleotides, cAMP, and cGMP, respectively, leading to the activation of PKA and subsequent phosphorylation events that may increase nucleobindin's ability to bind calcium and participate in signaling. Similarly, A23187, Thapsigargin, and Ionomycin, all facilitate the elevation of intracellular calcium levels, which is paramount for nucleobindin's role in calcium signaling; A23187 acts as an ionophore, Thapsigargin inhibits SERCA pumps, and Ionomycin is a calcium ionophore. EGCG, while its primary role is not directly linked to calcium signaling, can influence these pathways and, therefore, the activity of nucleobindin.
Nucleobindin activators are an array of chemical compounds that serve to enhance the functional activity of nucleobindin through modulation of intracellular calcium dynamics and signaling pathways. Forskolin and Isoproterenol, which elevate cAMP levels, indirectly increase nucleobindin activity by activating PKA, which can phosphorylate nucleobindin or associated regulatory proteins, enhancing its calcium-binding and signaling functions. Compounds like BAY K8644 and Calcimycin directly augment intracellular calcium levels, which is central to the activity of nucleobindin, thus potentially amplifying its role in calcium signaling. Thapsigargin and Cyclopiazonic Acid disrupt calcium reuptake into the endoplasmic reticulum by inhibiting SERCA pumps, leading to increased cytosolic calcium that can bind to nucleobindin, enhancing its regulatory functions. Ryanodine and FPL 64176, by modulating the activity of calcium release channels and influx pathways, can also indirectly potentiate the signaling roles of nucleobindin.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin directly elevates cAMP levels which enhances nucleobindin activity by activating PKA. This leads to phosphorylation events that can increase nucleobindin's binding to calcium and its role in calcium signaling pathways. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-specific inhibitor of phosphodiesterases, which prevents the breakdown of cAMP and cGMP, thereby indirectly enhancing the signaling pathways that nucleobindin is involved in, particularly those related to calcium homeostasis. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is an ionophore that increases intracellular calcium levels, thus potentially enhancing nucleobindin's calcium-binding activity and modulating its role in the calcium signaling pathways. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a polyphenol that can modulate various signaling pathways, one of them could enhance the activity of nucleobindin by altering calcium signaling and thus influencing its role in cellular processes. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that can increase intracellular calcium concentration, thereby indirectly enhancing nucleobindin activity due to its calcium-binding properties. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a MEK inhibitor that can modulate MAPK/ERK signaling, potentially altering the phosphorylation state of proteins and indirectly influencing nucleobindin's interaction with other signaling molecules. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor, which can alter AKT signaling and potentially enhance nucleobindin's role in calcium signaling pathways as they can be interconnected. | ||||||
SK&F 96365 | 130495-35-1 | sc-201475 sc-201475B sc-201475A sc-201475C | 5 mg 10 mg 25 mg 50 mg | $103.00 $158.00 $397.00 $656.00 | 2 | |
SKF-96365 is an inhibitor of receptor-mediated calcium entry channels, which can modulate calcium influx and subsequently enhance nucleobindin's calcium-related activities. | ||||||
Ruthenium red | 11103-72-3 | sc-202328 sc-202328A | 500 mg 1 g | $188.00 $250.00 | 13 | |
Ruthenium Red is an inhibitor of calcium uptake by mitochondria and other calcium channels, potentially enhancing the cytosolic calcium levels and thus the activity of calcium-binding proteins like nucleobindin. | ||||||
Nicotinic Acid | 59-67-6 | sc-205768 sc-205768A | 250 g 500 g | $62.00 $124.00 | 1 | |
Nicotinic Acid, or Niacin, can influence intracellular calcium levels and has been shown to interact with G-protein coupled receptors, potentially enhancing nucleobindin's activity by modulating its calcium-binding properties. | ||||||